HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Feb. 9, 2006--Nymox Pharmaceutical Corporation (NASDAQ:NYMX) has exciting new and innovative products and approaches in development for the treatment of Alzheimer’s disease. Alzheimer’s disease is a dreaded fatal brain disease of the elderly. An estimated 4.5 million Americans and more than 15 million people around the world suffer from the disease. While there are drug treatments available to reduce symptoms, there is no cure for the illness.
